Medical Care Technologies Inc Stock Price, News & Analysis

Medical Care Technologies (OTC Pink: MDCE) announced a strategic marketing partnership with iHeartRadio on December 11, 2025 to promote MDCE's upcoming health and wellness apps.

The collaboration will use iHeartRadio's network of radio stations, podcasts, and digital channels, citing a reach of over 270 million monthly listeners. MDCE also said it is developing an AI-based digital marketing agency that will launch in 2026 to support its AI applications and promotional efforts.

Medical Care Technologies (OTC PINK:MDCE) announced on December 10, 2025 that its subsidiary Real Game Used (RGU) reached a milestone in sports memorabilia authentication using AI-based pattern recognition and game-used wear detection.

In the past 30 days, RGU authenticated more than 100 premium items with a combined potential value of just over $10 million, highlighting the subsidiary's traction and the company's diversified portfolio.

The release emphasizes RGU's advanced AI-driven processes and notes ongoing work in medical applications at the parent company. For more information, visit realgameused.com and medicalcaretechnologies.com.

Medical Care Technologies (OTC Pink: MDCE) announced increased trading activity and shareholder engagement as of December 9, 2025, citing a stabilization of its share structure after the close of dilution tied to a prior Regulation A offering.

The company highlighted accelerating development of AI health tools, including a Google-backed AI dermatology and wound-monitoring platform for melanoma detection and chronic wound management, plus expanded technical advisory and integration efforts as catalysts for renewed investor interest.

Management said these advances support a path toward consumer testing, commercialization, and long-term revenue execution, and that further updates will follow as execution milestones are reached.

Medical Care Technologies (OTC Pink: MDCE) announced on December 8, 2025 that it has integrated Derm Foundation, a Google-backed pretrained dermatology imaging model, into its soon-to-launch AI wound and skin monitoring mobile platform.

The integration provides melanoma risk classification, chronic-wound progress tracking, data-efficient classification for conditions like psoriasis and dermatitis, automated image-quality checks, and HTTPS API integration for rapid mobile deployment. The company positions the app to enable earlier melanoma detection and reduce preventable hospitalizations by detecting infection risk and wound deterioration from smartphone images.

Company claims note melanoma early-detection survival can reach up to 99% and cite chronic wounds affecting 50 million+ people globally; the app targets rural, underserved and telehealth use cases.

Medical Care Technologies (OTC Pink: MDCE) announced its Regulation A Tier 1 offering will formally conclude on December 6, 2025, ending the dilution period tied to that offering and stopping further share issuance under Reg A.

The company said proceeds from the offering, together with an intentionally lean cost structure, have positioned MDCE to focus on product launches, revenue expansion, and AI innovation throughout 2026. Planned initiatives include a debut consumer-facing nutrition intelligence and recipe generation mobile platform and continued growth of subsidiaries Infinite Auctions and Real Game Used.

Medical Care Technologies (OTC Pink: MDCE) announced on December 4, 2025 a strategic acceleration toward AI-driven health and wellness mobile applications.

The company says it will leverage two operating subsidiaries, Infinite Auctions (since 2016) and Real Game Used (since 2017), as stable revenue and brand pillars while shifting focus to build a catalog of AI apps for medical pre-screening, nutrition, wellness, and food intelligence. MDCE identified the first product as a food and recipe AI mobile app positioned in a multi-billion-dollar market and described this release as a foundation for broader consumer health AI offerings.

Medical Care Technologies (OTC Pink: MDCE) on December 3, 2025 described a lean AI operating model that relies on outsourcing and API extensions to reduce overhead and increase agility.

The company contrasted its approach with large AI firms that invest hundreds of millions in proprietary infrastructure, saying MDCE avoids heavy capital and remains flexible. MDCE noted it has a pending patent application but is not dependent on that approval to continue development or deliveries. Management emphasized the model supports faster pivots, lower fixed costs, and continued innovation while minimizing reliance on single intellectual property outcomes.

Medical Care Technologies (OTC PINK: MDCE) is expanding development of consumer-grade AI pre-health screening mobile apps to detect early warning signs of serious conditions and prompt timely medical follow-up.

The initiative builds on MDCE's prior work in early melanoma detection and broadens its AI models to assess dermatology (skin lesions), ocular health markers, and lifestyle and health-behavior risk trends. The tools are described as deep-learning models trained on medical datasets and designed to provide consumer-friendly preliminary screening insights via mobile devices.

Management emphasizes early detection and aims to make proactive screening technology widely accessible from smartphones.

Medical Care Technologies (OTC PINK: MDCE) announced on December 1, 2025 that its first consumer AI mobile application has entered Apple iOS TestFlight, described as the final testing phase before App Store release. The app targets a $13.4 billion global health and nutrition app market and represents MDCE's first major consumer product outside its medical roadmap.

The company plans a sequential rollout: complete iOS TestFlight, obtain App Store approval and launch iOS, begin Google Play testing, then pursue a global Android launch after Google approval. Management said the app showcases internal development and AI capabilities and that a leading marketing agency will be engaged at launch. MDCE will provide ongoing investor updates as testing and feature refinement continue.